null
Loading... Please wait...
FREE SHIPPING on All Unbranded Items LEARN MORE
Print This Page

Preclinical Drug Development

List Price: $280.00
SKU:
9781420084726
Quantity:
Minimum Purchase
25 unit(s)
  • Availability: Confirm prior to ordering
  • Branding: minimum 50 pieces (add’l costs below)
  • Check Freight Rates (branded products only)

Branding Options (v), Availability & Lead Times

  • 1-Color Imprint: $2.00 ea.
  • Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
  • Belly-Band Wrap: $2.50 ea. (full-color printed)
  • Set-Up Charge: $45 per decoration
FULL DETAILS
  • Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
  • Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
  • Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
  • RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
  • Product Details

    Author:
    Mark Rogge, David R. Taft
    Format:
    Hardcover
    Pages:
    380
    Publisher:
    CRC Press (September 25, 2009)
    Imprint:
    CRC Press
    Language:
    English
    Audience:
    Professional and scholarly
    ISBN-13:
    9781420084726
    Weight:
    30.375oz
    Dimensions:
    7" x 10"
    File:
    TAYLORFRANCIS-TayFran_261001045153970-20261001.xml
    Folder:
    TAYLORFRANCIS
    List Price:
    $280.00
    Country of Origin:
    United States
    Pub Discount:
    30
    Series:
    Drugs and the Pharmaceutical Sciences
    Case Pack:
    20
    As low as:
    $266.00
    Publisher Identifier:
    P-CRC
    Discount Code:
    H
  • Overview

    This volume discusses the broad and complicated realm of preclinical drug development. Topics discussed include pharmacokinetics, modeling and simulation, formulation and routes of administration, toxicity evaluations, the assessment of drug absorption and metabolism, and interspecies scaling. The authors also examine lead molecule selection and optimization via profiling and screening using in silico and in vitro toxicity evaluations. The book includes case studies on preclinical pharmacokinetic-pharmacodynamic modeling and simulation in drug development, a review of ICH preclinical guidelines, and experimental methods used to study membrane drug transport and metabolism.